RxDoctor Payments Data
★ My doctorsLook up a doctor →

Mohamed Azeem Latib, MD

Interventional Cardiology · Bronx, NYNPI 1285108910

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (33.9%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Boston Scientific at 36.7% of the total. 2025 is the largest year on record at $345,934, 5.5 times the $62,865 reported in 2019. Among interventional cardiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$816,294in general payments, 2019–2025

Across 1,203 payments — averaging $678.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$300K
  • Medtronic$195K
  • Johnson & Johnson$140K
  • Abbott$78K
  • Philips North America LLC$42K
  • Edwards Lifesciences$30K
  • plus $32K from 21 others
$3,879,376in research payments, 2019–2025

Across 1,049 payments — averaging $3698.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$2.1M
  • Boston Scientific$1.1M
  • Abbott$407K
  • Medtronic$251K
  • Shockwave Medical, Inc$38K
  • Amgen$3K

What the payments were for

  • Consulting fees$162,13020%
  • Speaking & faculty fees$236,50429%
  • Grants$7,9851%
  • Travel & lodging$80,60110%
  • Food & beverage$52,3556%
  • Other$276,71934%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific85$299,876
Medtronic(2 entities)521$195,105
Johnson & Johnson3$139,782
Abbott154$78,179
Philips North America LLC39$41,923
Edwards Lifesciences299$29,736
Ancora Heart, Inc.13$12,143
Penumbra, Inc.9$5,324
Centerline Biomedical Inc.1$2,526
GE HealthCare4$1,967
Croivalve Inc4$1,644
Shockwave Medical, Inc20$1,533
Biosense Webster, Inc.1$1,500
Abiomed7$1,005
W. L. Gore & Associates, Inc.12$993
Cordis US CORP.1$790
Jenavalve Technology, Inc.2$364
Inari Medical, Inc.13$328
Cardiovascular Systems Inc.2$307
Stryker4$289
Terumo Medical Corporation3$275
Siemens Medical Solutions USA, Inc.1$171
Teleflex LLC1$170
Cardiac Dimensions, Inc.1$158
Angiodynamics, Inc.1$127
Cvrx, Inc.1$60
Novartis1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$816,294 in reported general payments places this provider in the 95th percentile of 382 interventional cardiology providers in New York.

See all interventional cardiology providers in New York →

Medicare billing

Part B allowed, 2024
$299,494
Medicare patients
251
Services billed
715

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Bronx

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →